Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)
NCT: NCT04502316 · TERMINATED
광고
NCT IDNCT04502316
상태TERMINATED
시작일2020-06-26
완료2026-06-30
SponsorCVRx, Inc. (INDUSTRY)
First posted
Last updated
간략 요약
The purpose of this registry is to develop valid scientific evidence of the safety and benefit of Barostim Therapy in the commercial setting in patients with heart failure with reduced ejection fraction (HFrEF) that were recently implanted with the Barostim System.
공식 출처
ClinicalTrials.gov에서 보기 →데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.